MG Valsecchi

Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group

Andrea Biondi, MG Valsecchi, Taku Seriu et al. · Leukemia · 2000 · 116 citations · Full text

Medicine, Hematology, Oncology +17

Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia

Chiara Messina, MG Valsecchi, Maurizio Aricò et al. · Bone Marrow Transplantation · 1998 · 41 citations

Medicine, Hematology, Oncology +14

Transplant-related toxicity and mortality: an AIEOP prospective study in 636 pediatric patients transplanted for acute leukemia

Adriana Balduzzi, MG Valsecchi, Daniela Silvestri et al. · Bone Marrow Transplantation · 2002 · 35 citations · Full text

Medicine, Oncology, Pediatrics +17

Treatment of Pediatric non‐Hodgkin lymphomas in a country with limited resources: Results of the first national protocol in Nicaragua

F. Baez, Marta Pillon, Luca Manfredini et al. · Pediatric Blood & Cancer · 2006 · 20 citations · Full text

Medicine, Oncology, Pediatrics +11